Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
Pre-publication versions of this article are available by contacting email@example.com.
|30 Jun 2007||Submitted||Original manuscript|
|31 Jul 2007||Reviewed||Reviewer Report - Franz Schaefer|
|20 Aug 2007||Author responded||Author comments - Andreas Serra|
|Resubmission - Version 2|
|20 Aug 2007||Submitted||Manuscript version 2|
|15 Sep 2007||Editorially accepted|
|15 Sep 2007||Article published||10.1186/1471-2369-8-13|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.